Collapsing Focal Segmental Glomerulosclerosis Resulting from a Single Dose of Zoledronate

被引:16
作者
Neyra, Javier A. [1 ]
Vaidya, Omkar U. [1 ]
Hendricks, Allen [2 ]
Sambandam, Kamalanathan K. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Div Nephrol, Dept Internal Med, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
来源
NEPHRON EXTRA | 2014年 / 4卷 / 03期
关键词
Focal segmental glomerulosclerosis; Bisphosphonates; Zoledronate;
D O I
10.1159/000366450
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Bisphosphonates are commonly used for the treatment of osteoporosis, Paget's disease, multiple myeloma and hypercalcemia. Collapsing focal segmental glomerulosclerosis (FSGS) is known to occur uncommonly with exposure to bisphosphonates, specifically pamidronate and alendronate; it has rarely and equivocally been reported with zoledronate therapy. We describe the case of a 36-year-old African American female with metastatic breast cancer who presented with nephrotic-range proteinuria and acute kidney injury within 2 weeks of exposure to a single dose of zoledronate. The patient had a partial recovery of her renal function and showed improved proteinuria to a subnephrotic level after discontinuing zoledronate. In contrast to 2 prior reports of zoledronate-induced collapsing FSGS, the causative role of the exposure described here is certain. Our case necessitates the addition of zoledronate to the list of known causes of collapsing FSGS. Furthermore, it highlights the importance of periodically monitoring renal function and urine protein excretion with the use of zoledronate, which allows prompt diagnosis and withdrawal of the drug to increase the probability of renal recovery. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:168 / 174
页数:7
相关论文
共 50 条
  • [31] Rituximab for refractory focal segmental glomerulosclerosis
    Makiko Nakayama
    Koichi Kamei
    Kandai Nozu
    Kentaro Matsuoka
    Atsuko Nakagawa
    Mayumi Sako
    Kazumoto Iijima
    Pediatric Nephrology, 2008, 23 : 481 - 485
  • [32] Syphilis masquerading as focal segmental glomerulosclerosis
    Hartley, A. J.
    Rajakariar, R.
    Sheaff, M.
    Buckland, M.
    Goh, B.
    O'Connell, R.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (07) : 529 - 531
  • [33] Rituximab for refractory focal segmental glomerulosclerosis
    Nakayama, Makiko
    Kamei, Koichi
    Nozu, Kandai
    Matsuoka, Kentaro
    Nakagawa, Atsuko
    Sako, Mayumi
    Iijima, Kazumoto
    PEDIATRIC NEPHROLOGY, 2008, 23 (03) : 481 - 485
  • [34] Pathogenesis of Focal and Segmental Glomerulosclerosis: A Review
    Akash, Nabil
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2007, 18 (02) : 226 - 230
  • [35] Mechanisms of Scarring in Focal Segmental Glomerulosclerosis
    Sun, Ke
    Xie, Qionghong
    Hao, Chuan-Ming
    KIDNEY DISEASES, 2021, 7 (05) : 350 - 358
  • [36] Microarray analysis of focal segmental glomerulosclerosis
    Schwab, K
    Witte, DP
    Aronow, BJ
    Devarajan, P
    Potter, SS
    Patterson, LT
    AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (04) : 438 - 447
  • [37] Precision medicine for focal segmental glomerulosclerosis
    Xie, Yi
    Liu, Fei
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2024, 43 (06) : 709 - 723
  • [38] Focal segmental glomerulosclerosis associated with acromegaly
    Takai, M
    Izumino, K
    Oda, Y
    Terada, Y
    Inoue, H
    Takata, M
    CLINICAL NEPHROLOGY, 2001, 56 (01) : 75 - 77
  • [39] Focal segmental glomerulosclerosis: recent advances
    Pollak, Martin R.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2008, 17 (02) : 138 - 142
  • [40] Focal Segmental Glomerulosclerosis and Kidney Transplantation
    Gheith, Osama
    Hassan, Rashad
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (04) : 257 - 264